Pyxis Oncology Names New CMO to Lead Development of Next-Gen Antibody-Drug Conjugates September 20, 2021
New JV from Upstart Biotechs Pyxis, Alloy Aims for Rapid Drug Development in Cancer, Autoimmune Diseases May 26, 2021
Alloy Therapeutics and Pyxis Oncology Form Kyma Therapeutics to Develop Novel Immune-Modulating Antibodies for Cancer and Autoimmune Diseases May 25, 2021
Pyxis Oncology Presents Preclinical Data and Details on Antibody-Drug Conjugate Candidates Supporting Therapeutic Potential April 27, 2021
